APA (7th ed.) Citation

A, L., RA, B., P, F., MA, D., D, M., JS, K., . . . S, W. (2014). Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 15(2), e72. https://doi.org/10.1097/PCC.0000000000000028

Chicago Style (17th ed.) Citation

A, Liveris, Bello RA, Friedmann P, Duffy MA, Manwani D, Killinger JS, Rodriquez D, and Weinstein S. "Anti-factor Xa Assay Is a Superior Correlate of Heparin Dose than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation*." Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 15, no. 2 (2014): e72. https://doi.org/10.1097/PCC.0000000000000028.

MLA (9th ed.) Citation

A, Liveris, et al. "Anti-factor Xa Assay Is a Superior Correlate of Heparin Dose than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation*." Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol. 15, no. 2, 2014, p. e72, https://doi.org/10.1097/PCC.0000000000000028.